Imricor Medical Systems, Inc. (ASX:IMR)

Market Cap	654.39M +43.7%
Revenue (ttm)	173.57K -84.0%
Net Income	-53.94M
EPS	-0.18
Shares Out	358.57M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,074,075
Open	1.860
Previous Close	1.825
Day's Range	1.790 - 1.860
52-Week Range	1.275 - 2.250
Beta	0.48
Analysts	Strong Buy
Price Target	2.96 (+64.9%)
Earnings Date	Nov 9, 2026

About Imricor Medical Systems

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company’s products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with except...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Country: United States
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: IMR

Financial Performance

In 2025, Imricor Medical Systems's revenue was $292,309, a decrease of -69.53% compared to the previous year's $959,424. Losses were -$25.32 million, -14.73% less than in 2024.

Financial numbers in USD

Analyst Summary

According to 4 analysts, the average rating for IMR stock is "Strong Buy." The 12-month stock price target is $2.96, which is an increase of 64.90% from the latest price.

Price Target

$2.96

(64.90% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 17, 2026

Data Sources Report a data error